ONCOVALUE Consortium Meets in Porto
On 16–17 March 2026, ONCOVALUE partners gathered in Porto, Portugal, for a two-day consortium meeting hosted at the Instituto Português de Oncologia do Porto (IPO-Porto). The meeting brought together project partners to review progress, exchange insights, and align on the next steps towards delivering value-based oncology care across Europe. The first day focused on scientific […]
ONCOVALUE newsletter #3 now published
ONCOVALUE has continued to make substantial progress toward its overarching goal: enabling value-based oncology care through high-quality real-world data (RWD), AI-supported analytics, and a future-proof HTA framework. Discover the developments and achievements across the project’s work packages by reading our third project newsletter! Download the issue at this link.
Harnessing real-world data to redefine value in oncology care
Can real-world data make cancer care more sustainable and cost-effective? In this video, Valesca Retel of the Netherlands Cancer Institute (NKI) explores how the ONCOVALUE project is tackling one of healthcare’s toughest challenges: generating robust real-world evidence to better understand the true value of innovative cancer therapies. By leveraging advanced analytics and AI, ONCOVALUE aims […]
Uniting Doctors and Data: Nora Franzen’s Work on ONCOVALUE and Beyond
What happens when clinicians and data scientists truly work together? In this video, Nora Franzen shares how her experience at the Netherlands Cancer Institute (NKI) – bridging clinical expertise and data science within the ONCOVALUE research – shaped the way she thinks about cancer care today. Now an assistant professor at Erasmus School of Health […]
Redefining cancer care through data and collective intelligence
Cancer care is entering a defining moment. As data volumes grow and clinical complexity increases, artificial intelligence is no longer a future promise – it is becoming a practical force reshaping how oncology is delivered. Across Europe and beyond, AI is moving from experimentation to real-world impact, helping clinicians diagnose earlier, personalise treatments, and improve […]
Great momentum for ONCOVALUE at the HIMSS Italian Community Member Meeting
PNO Innovation Italia successfully joined the HIMSS Italian Community Member Meeting, boosting ONCOVALUE’s visibility and sparking fresh connections across Italy’s vibrant digital health ecosystem. The event brought together innovators, clinicians, tech providers, and institutional leaders, an ideal stage to spotlight ONCOVALUE’s bold mission: transforming oncology with high-quality Real-World Data and AI-driven insights to better understand […]
PNO Innovation Italia at Investing for Life 2025 – event highlights!
As a partner of ONCOVALUE, PNO Innovation Italia took part in the Investing for Life event (2–3 December 2025, Milan), helping to strengthen the project’s visibility and expand its European network within the life-sciences ecosystem. During this high-level event, PNO Innovation Italia showcased ONCOVALUE’s mission: advancing value-based oncology care through high-quality Real-World Data and AI-driven […]
Guidance for DPIA Practices: A New Whitepaper for EU-Funded Projects
As health research becomes increasingly data-driven, ensuring robust data protection and ethical handling of sensitive information is more important than ever. When dealing with technologies like Federated Learning and cross-border data sharing, the risks to privacy grow, and so does the need for clear, actionable guidance. To address this, ONCOVALUE is proud to have contributed […]
Tracking Cancer Over Time: ONCOVALUE’s Unique Annotated Dataset
ONCOVALUE has developed a unique annotated dataset to train an AI-based imaging tool designed to support the assessment of metastatic breast cancer. With Siemens Healthineers leading its development, the tool ultimately aims to help evaluate which therapies are effective by providing objective, image-based information on disease progression. Using longitudinal medical imaging data (i.e. imaging data […]
ONCOVALUE Joins the Cancer Survivorship – Artificial Intelligence Working Group (CS-AIW) Cluster
We are excited to announce that ONCOVALUE has officially joined the Cancer Survivorship – Artificial Intelligence Working Group (CS-AIW) cluster, a European initiative focused on advancing cancer research through the application of artificial intelligence (AI). The CS-AIW cluster brings together European projects dedicated to improving cancer outcomes. Through collaboration and shared expertise, this cluster aims […]